Triacetoxyperiodinane → n-(2-Benzooxazol-2-yl-1-methoxymethyl-2-oxo-ethyl)-2-(2-difluoromethoxy-benzylsulfonylmethyl)-4-morpholin-4-yl-4-oxo-butyramide
Reaction equation
[O:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[CH:10]([OH:43])[CH:11]([NH:15][C:16](=[O:42])[CH:17]([CH2:27][S:28]([CH2:31][C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=1[O:38][CH:39]([F:41])[F:40])(=[O:30])=[O:29])[CH2:18][C:19]([N:21]1[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1)=[O:20])[CH2:12][O:13][CH3:14].CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O.[O-]S([O-])(=S)=O.[Na+].[Na+].C([O-])(O)=O.[Na+]>>[O:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[C:10](=[O:43])[CH:11]([NH:15][C:16](=[O:42])[CH:17]([CH2:27][S:28]([CH2:31][C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][C:33]=1[O:38][CH:39]([F:41])[F:40])(=[O:30])=[O:29])[CH2:18][C:19]([N:21]1[CH2:26][CH2:25][O:24][CH2:23][CH2:22]1)=[O:20])[CH2:12][O:13][CH3:14]Participants
Reactant 3
Product 1
Procedure
This amide (150 mg, 0.24 mmol) was treated with Dess-Martin periodinane (178 mg, 0.36 mmol) at room temperature. After stirring for 1 hour, 5 ml of saturated Na2S2O3—NaHCO3 were added. After a further 0.5 hours, the reaction mixture was extracted with ethyl acetate, washed with brine, dried with MgSO4 and concentrated. The residue was purified with silica gel column chromatography to yield 39 mg of N-(2-Benzooxazol-2-yl-1-methoxymethyl-2-oxo-ethyl)-2-(2-difluoromethoxy-benzylsulfonylmethyl)-4-morpholin-4-yl-4-oxo-butyramide; H1 NMR(DMSO-d): 8.97, 8.8(1H, dd, J=5.6 Hz, J=5.6 Hz, NH, diastereomeric), 8.02–7.94(1H, m), 7.9–7.84(1H, m), 7.66–7.58(1H, m), 7.55–7.38(3H, m), 7.3–7.18(2H, m), 7.1(1H, t, J=73.6 Hz), 5.54–5.42(1H, m), 4.6–4.4(4H, m), 3.92–3.84(1H, m), 3.82–3.72(1H, m), 3.68–3.1(11H, m), 2.7–2.56(1H, m), 1.7–1.55(1H, m), 1.3–1(1H, m); MS: 622.4(M−1), 624.3(M+1), 646.3(M+Na).
Workup
- waitAfter a further 0.5 hours
- extractionthe reaction mixture was extracted with ethyl acetate
- washwashed with brine
- dry with materialdried with MgSO4
- concentrationconcentrated
- customThe residue was purified with silica gel column chromatography
Sources & evidence
- ORD record
- ord-6363e92771364ca586b33c8005bc81db
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07064123B1
Reaction notes
Loading…